Edition:
United States

Syndax Pharmaceuticals Inc (SNDX.OQ)

SNDX.OQ on NASDAQ Stock Exchange Global Select Market

9.60USD
11:28am EST
Change (% chg)

$0.33 (+3.56%)
Prev Close
$9.27
Open
$9.26
Day's High
$9.67
Day's Low
$9.26
Volume
11,497
Avg. Vol
75,429
52-wk High
$15.65
52-wk Low
$7.43

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.31 -0.678
Jun '17 0.31 -0.700
Mar '17 0.31 -0.711
FY 2016 Dec '16 0.31 -0.740
Sep '16 0.31 -0.836
Jun '16 0.31 -0.470
Mar '16 0.31 -0.727
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 2 0.40 0.41 0.39 --
Quarter Ending Jun-18 2 0.40 0.41 0.39 --
Year Ending Dec-18 7 1.20 1.63 0.00 0.74
Earnings (per share)
Quarter Ending Mar-18 5 -0.72 -0.67 -0.78 --
Quarter Ending Jun-18 5 -0.74 -0.69 -0.79 --
Year Ending Dec-18 8 -3.20 -2.54 -4.47 -3.77
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 32.23 35.64
P/E High - Last 5 Yrs. -- 41.43 46.80
P/E Low - Last 5 Yrs. -- 23.37 24.18
Beta -- 0.81 0.81
Price to Sales (TTM) 185.32 6.23 8.67
Price to Book (MRQ) 2.14 4.34 5.21
Price to Tangible Book (MRQ) 2.34 4.82 6.35
Price to Cash Flow (TTM) -- 23.04 26.03
% Owned Institutions 85.42 1.25 2.27

Dividends

  Company industry sector
Dividend Yield -- 1.59 1.51
Dividend Yield - 5 Year Avg -- 2.15 2.01
Dividend 5 Year Growth Rate -- 4.24 5.24
Payout Ratio(TTM) -- 45.32 44.74

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 0.00 8.65 9.21
Sales (TTM) vs TTM 1 Yr. Ago 0.00 6.38 7.55
Sales - 5 Yr. Growth Rate -- 9.89 10.21
EPS (MRQ) vs Qtr. 1 Yr. Ago 18.88 14.70 16.86
EPS (TTM) vs TTM 1 Yr. Ago -11.43 -- --
EPS - 5 Yr. Growth Rate -- 10.39 11.51
Capital Spending - 5 Yr. Growth Rate 100.78 14.63 14.77

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.39 2.42
Current Ratio (MRQ) 8.73 3.34 3.38
LT Debt to Equity (MRQ) 0.00 9.17 12.01
Total Debt to Equity (MRQ) 0.00 12.36 15.38
Interest Coverage (TTM) -- 45.25 39.15

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.23 54.84
Gross Margin - 5 Yr. Avg. -- 52.57 52.61
EBITD Margin (TTM) -4,366.56 -- --
EBITD - 5 Yr. Avg -5,568.17 18.47 9.77
Operating Margin (TTM) -4,393.94 11.50 2.53
Operating Margin - 5 Yr. Avg. -5,577.48 14.27 5.00
Pre-Tax Margin (TTM) -4,304.34 11.87 3.34
Pre-Tax Margin - 5 Yr. Avg. -6,091.55 14.55 5.26
Net Profit Margin (TTM) -4,304.34 8.24 -0.18
Net Profit Margin - 5 Yr. Avg. -6,091.55 10.88 1.54
Effective Tax Rate (TTM) -- 22.44 22.12
Effective Tax Rate - 5 Yr. Avg. -- 23.60 24.22

Efficiency

  Company industry sector
Revenue/Employee (TTM) 38,125 922,196,718 822,216,427
Net Income/Employee (TTM) -1,641,031 107,909,384 96,151,835
Receivable Turnover (TTM) 3.16 5.30 5.40
Inventory Turnover (TTM) -- 2.60 3.51
Asset Turnover (TTM) 0.01 0.93 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -43.36 11.13 10.70
Return on Assets - 5 Yr. Avg. -63.14 12.64 12.00
Return on Investment (TTM) -47.99 14.02 13.57
Return on Investment - 5 Yr. Avg. -91.27 16.55 15.72
Return on Equity (TTM) -55.12 15.49 15.19
Return on Equity - 5 Yr. Avg. -- 17.63 16.94
  1 Year 3 Year 5 Year
Sales % 94.58 -- --
EPS (TTM) % 46.14 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Syndax Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -11.63 -7.63 31 53
13 Week 11.96 7.12 69 40
26 Week -16.26 -24.39 18 20
52 Week -17.89 -28.93 28 28
YTD 5.82 4.16 74 39
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 85.42%
# of Holders: 121
Total Shares Held: 20,834,123
3 Mo. Net Change: 1,969,456
# New Positions: 22
# Closed Positions: 14
# Increased Positions: 55
# Reduced Positions: 40
# Net Buyers: 15
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.